Inventiva IVEVF
NASDAQ IVEVF
$3.59 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Inventiva (IVEVF) Accounts Payables (2018 - 2025)

Inventiva (IVEVF) posted Accounts Payables of $30.3 million for Q4 2025, down 22.9% on a QoQ basis from $39.3 million in Q2 2025, and down 13.76% year-over-year from $35.1 million in Q4 2024.

Analysis

Inventiva (IVEVF) Accounts Payables (2018 - 2025) Analysis & Trends

Inventiva has reported Accounts Payables for 8 years, with the latest figure at $30.3 million in Q4 2025.

  • On a quarterly basis, Accounts Payables fell 13.76% year-over-year to $30.3 million in Q4 2025; TTM through Dec 2025 was $30.3 million, a 13.76% decrease from a year earlier, with the FY2025 full-year figure at $30.3 million, down 13.76% from the prior year.
  • Accounts Payables was $30.3 million for Q4 2025 at Inventiva, down from $39.3 million in the prior quarter.
  • The five-year high for Accounts Payables was $40.5 million in Q4 2023, with the low at $7538.2 in Q2 2024.
  • Average Accounts Payables over 5 years is $22.8 million, with a median of $19.8 million recorded in 2022.
  • The sharpest annual moves came in 2024 and 2025: Accounts Payables plunged 99.98% in 2024, then soared 521010.2% in 2025.
  • Over 5 years, Accounts Payables stood at $16.7 million in 2021, then gained by 18.24% to $19.8 million in 2022, then jumped by 105.26% to $40.5 million in 2023, then retreated by 13.38% to $35.1 million in 2024, then dropped by 13.76% to $30.3 million in 2025.
  • The last three Accounts Payables figures came in at $30.3 million (Q4 2025), $39.3 million (Q2 2025), and $35.1 million (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 646.43 Bn 625.67 Bn 17.26 Bn 9.22 Bn
2 AbbVie 442.46 Bn 435.89 Bn 12.70 Bn 33.30 Bn
3 Merck 366.77 Bn 359.63 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 266.59 Bn 258.90 Bn 11.24 Bn 4.26 Bn
5 Pfizer 159.14 Bn 147.45 Bn 10.94 Bn 4.58 Bn
6 Sanofi 52.40 Bn 45.02 Bn 10.79 Bn 8.31 Bn
7 Revolution Medicines 44.08 Bn 44.08 Bn - 88.42 Mn
8 Incyte 25.38 Bn 20.85 Bn 1.57 Bn 250.40 Mn
9 United Therapeutics 21.53 Bn 18.87 Bn 683.80 Mn 497.80 Mn
10 Inventiva 693.72 Mn 693.72 Mn - 30.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 30.28 Mn
Jun 30, 2025 39.28 Mn
Dec 31, 2024 35.12 Mn
Jun 30, 2024 7,538.21
Dec 31, 2023 40.54 Mn
Jun 30, 2023 31.24 Mn
Dec 31, 2022 19.75 Mn
Jun 30, 2022 15.21 Mn
Dec 31, 2021 16.70 Mn
Jun 30, 2021 12.27 Mn
Mar 31, 2021 10.48 Mn
Dec 31, 2020 8.25 Mn
Jun 30, 2020 9.39 Mn
Dec 31, 2019 8.29 Mn
Dec 31, 2018 9.56 Mn